KR960009417B1 - 순환기용제 - Google Patents

순환기용제 Download PDF

Info

Publication number
KR960009417B1
KR960009417B1 KR1019880016362A KR880016362A KR960009417B1 KR 960009417 B1 KR960009417 B1 KR 960009417B1 KR 1019880016362 A KR1019880016362 A KR 1019880016362A KR 880016362 A KR880016362 A KR 880016362A KR 960009417 B1 KR960009417 B1 KR 960009417B1
Authority
KR
South Korea
Prior art keywords
physiologically acceptable
acid addition
acceptable acid
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019880016362A
Other languages
English (en)
Korean (ko)
Other versions
KR890009399A (ko
Inventor
요시아키 요시쿠니
노부토시 고지마
카즈야 모리
Original Assignee
닛본 신야쿠 가부시기가이샤
아만 히데아키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닛본 신야쿠 가부시기가이샤, 아만 히데아키 filed Critical 닛본 신야쿠 가부시기가이샤
Publication of KR890009399A publication Critical patent/KR890009399A/ko
Application granted granted Critical
Publication of KR960009417B1 publication Critical patent/KR960009417B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019880016362A 1987-12-09 1988-12-09 순환기용제 Expired - Fee Related KR960009417B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP87-311348 1987-12-09
JP?62-311348 1987-12-09
JP31134887 1987-12-09

Publications (2)

Publication Number Publication Date
KR890009399A KR890009399A (ko) 1989-08-01
KR960009417B1 true KR960009417B1 (ko) 1996-07-19

Family

ID=18016066

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016362A Expired - Fee Related KR960009417B1 (ko) 1987-12-09 1988-12-09 순환기용제

Country Status (11)

Country Link
EP (1) EP0319986B1 (https=)
KR (1) KR960009417B1 (https=)
AT (1) ATE149836T1 (https=)
BE (1) BE1004874A4 (https=)
CA (1) CA1316831C (https=)
CH (1) CH677610A5 (https=)
DE (1) DE3855824T2 (https=)
FR (1) FR2626470B1 (https=)
GB (2) GB8827701D0 (https=)
IL (1) IL88573A (https=)
SE (1) SE502110C2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001319A1 (en) * 1988-08-10 1990-02-22 The Australian National University Use of castanospermine as an anti-inflammatory and immunosuppressant agent
JP2001500849A (ja) * 1996-08-14 2001-01-23 ヒー チュン，ミュン プラスミン除去治療
EP1903034A1 (en) * 2006-09-19 2008-03-26 Technische Universität Graz Iminosugar glycoconjugates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943946B2 (ja) * 1978-04-28 1984-10-25 日本新薬株式会社 Ｎ−アルケニルモラノリン誘導体
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 Ｎ−置換モラノリン誘導体
JPS6026387B2 (ja) * 1979-01-20 1985-06-24 日本新薬株式会社 シンナミルモラノリン誘導体
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5943949B2 (ja) * 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのｎ−置換誘導体
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
JPS60224675A (ja) * 1984-04-24 1985-11-09 Meiji Seika Kaisha Ltd 新規１−デオキシノジリマイシン誘導体およびそれを含有する血中脂質低下剤
CA1327970C (en) * 1985-05-24 1994-03-22 Paul S. Liu Isolation of castanospermine and its use as an antidiabetic agent
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity

Also Published As

Publication number Publication date
GB2213374B (en) 1992-01-29
SE8804436D0 (sv) 1988-12-08
FR2626470B1 (fr) 1994-12-09
KR890009399A (ko) 1989-08-01
ATE149836T1 (de) 1997-03-15
CA1316831C (en) 1993-04-27
EP0319986B1 (en) 1997-03-12
GB2213374A (en) 1989-08-16
SE502110C2 (sv) 1995-08-21
GB8827701D0 (en) 1988-12-29
DE3855824T2 (de) 1997-10-16
DE3855824D1 (de) 1997-04-17
SE8804436L (sv) 1989-06-10
CH677610A5 (https=) 1991-06-14
EP0319986A2 (en) 1989-06-14
BE1004874A4 (fr) 1993-02-16
FR2626470A1 (fr) 1989-08-04
GB8827927D0 (en) 1989-01-05
EP0319986A3 (en) 1992-09-30
IL88573A (en) 1994-05-30

Similar Documents

Publication Publication Date Title
US5192772A (en) Therapeutic agents
US4451454A (en) Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
HU182458B (en) Process for preparing enzyme derivatives with in vivo fibrinolytic activity
EP1098651B1 (de) Neue urokinase-inhibitoren
JPH07503231A (ja) 求核剤／酸化窒素・複合体およびその誘導体による血小板凝集の治療的阻害
US20100016356A1 (en) Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban
JPH04503524A (ja) 再潅流損傷の防止又は制限のための薬剤
KR960009417B1 (ko) 순환기용제
EP0491041A1 (en) Antiviral drug
JPH0525857B2 (https=)
JP2002527350A (ja) 発作を治療するのに有用なアミノ酸誘導体
JPH06234636A (ja) インターロイキン８を阻害するためのレフルノミドの使用
Uchiyama et al. Role of platelet-activating factor in aggregation of leukocytes and platelets in cerebral ischemia
JPH01250350A (ja) 循環器用剤
JP2018520128A (ja) 重水素化チエノピペリジン誘導体、調製方法、及びその使用
EP0096735B1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them
JPH0586931B2 (https=)
AU4242597A (en) Crystalline pharmaceutical product
US3810991A (en) A method of inducing fibrinolysis
CN113244225B (zh) 土槿皮乙酸在制备抗血小板药物中的应用
JP2005525336A (ja) 血栓性および炎症性障害の治療のためのナトリウム／水素交換体の阻害剤の使用
JPS59508B2 (ja) ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ
US20040097583A1 (en) Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders
JPS6322061A (ja) フエニルアラニン誘導体および蛋白分解酵素阻害剤
JPWO1989011852A1 (ja) 膵炎等治療剤

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19990720

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19990720

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000